在患有慢性阻塞性肺病的患者中,每周一次为期一年的肺康复
Yohei Kubori1, Yuji Yasuda2, Akira Tamaki3
1Department of Rehabilitation Medicine, Yasuda Clinic, Kyoto, JPN.
Cureus
|August 8, 2024
概括
本案例研究表明,一年的每周肺部康复 (PR) 可以有效地改善慢性阻塞性肺病 (COPD) 患者的运动能力和生活质量. 患者经历了显著的改善,没有任何不良事件.
科学领域:
- 肺部病理学 肺部病理学
- 康复医学 康复医学 康复医学
背景情况:
- 肺部康复 (PR) 改善慢性阻塞性肺部疾病 (COPD) 的结果,但通常侧重于短期影响.
- 在COPD管理中的长期PR疗效仍未得到充分研究.
研究的目的:
- 为了评估一年的可行性和有效性,每周一次的PR计划在患有II期COPD的患者.
- 评估长期PR后身体功能,呼吸障碍和生活质量的变化.
主要方法:
- 一个单一病例报告,一名84岁的男性患有COPDII期.
- 干预包括每周一次的运动训练,自我管理支持,呼吸技巧和呼吸肌肉伸展,持续一年.
- 身体功能 (6分钟步行距离),呼吸障碍和生活质量在干预前后被评估.
主要成果:
- 患者完成了一年的PR,没有任何不良事件.
- 观察到身体功能显著改善,呼吸障碍减少,生活质量提高.
- 六分钟的步行距离在3个月达到临床重要差异最小,并在6个月预测正常值.
结论:
- 每周一次,为期一年的肺部康复计划似乎是可行的和有效的,以改善COPD患者的长期结果.
- 这种方法可以提供一种可持续的策略来管理COPD症状并改善患者的福祉.
相关概念视频
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
192
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
192


